INTRODUCTION: HIV counseling and testing during labour can be emotional, but is important because it allows mothers and babies to receive PMTCT prophylaxis if previous identification of HIV infection has not occurred. The study explores how HIV testing and counseling during early labour affects women. METHODOLOGY: This was a qualitative exploratory study to understand women's experiences during early labor. From September to October 2009, we conducted 10 indepth interviews with women who tested for HIV during early labour. We recruited women who tested > 3 months previously and those who had never tested for HIV from the postpartum ward of Bwaila Hospital. Data were analyzed manually using the life story approach in order to examine and analyse subjective experiences of women and their constructions of the social world. Transcripts were read multiple times to understand meanings which participants attached to their experiences. We coded data according to emerging themes and subthemes. RESULTS: Ten women 20-35 years were interviewed. Eight women had unknown HIV status while two had known HIV results but re-tested to update their status. Four women were found HIV-positive while 6 were HIV-negative. The primary theme was that women appreciated and accepted HIV testing and counseling. Testing was accepted as a necessary step to protect the infant from HIV infection. Counseling was viewed as helpful for acceptance of HIV status. One key subtheme was that HIV positive women experienced disappointment about their HIV diagnosis, though this was outweighed by the knowledge that one could protect her infant. All women viewed the short time to complete the counseling and testing procedures as favourable. CONCLUSION: Labour testing is acceptable and should be promoted to enhance PMTCT services by identifying HIV positive women with unknown status. Counseling helps women to accept being found with HIV and seek appropriate services.
INTRODUCTION: HIV counseling and testing during labour can be emotional, but is important because it allows mothers and babies to receive PMTCT prophylaxis if previous identification of HIV infection has not occurred. The study explores how HIV testing and counseling during early labour affects women. METHODOLOGY: This was a qualitative exploratory study to understand women's experiences during early labor. From September to October 2009, we conducted 10 indepth interviews with women who tested for HIV during early labour. We recruited women who tested > 3 months previously and those who had never tested for HIV from the postpartum ward of Bwaila Hospital. Data were analyzed manually using the life story approach in order to examine and analyse subjective experiences of women and their constructions of the social world. Transcripts were read multiple times to understand meanings which participants attached to their experiences. We coded data according to emerging themes and subthemes. RESULTS: Ten women 20-35 years were interviewed. Eight women had unknown HIV status while two had known HIV results but re-tested to update their status. Four women were found HIV-positive while 6 were HIV-negative. The primary theme was that women appreciated and accepted HIV testing and counseling. Testing was accepted as a necessary step to protect the infant from HIV infection. Counseling was viewed as helpful for acceptance of HIV status. One key subtheme was that HIV positive women experienced disappointment about their HIV diagnosis, though this was outweighed by the knowledge that one could protect her infant. All women viewed the short time to complete the counseling and testing procedures as favourable. CONCLUSION: Labour testing is acceptable and should be promoted to enhance PMTCT services by identifying HIV positive women with unknown status. Counseling helps women to accept being found with HIV and seek appropriate services.
Authors: Karen M Megazzini; Namwinga Chintu; Sten H Vermund; David T Redden; Daniel W Krebs; Maureen Simwenda; Bushimbwa Tambatamba; Moses Sinkala; Jeffrey S A Stringer Journal: J Acquir Immune Defic Syndr Date: 2009-10-01 Impact factor: 3.731
Authors: Erik J Schouten; Andreas Jahn; Dalitso Midiani; Simon D Makombe; Austin Mnthambala; Zengani Chirwa; Anthony D Harries; Joep J van Oosterhout; Tarek Meguid; Anne Ben-Smith; Rony Zachariah; Lutgarde Lynen; Maria Zolfo; Wim Van Damme; Charles F Gilks; Rifat Atun; Mary Shawa; Frank Chimbwandira Journal: Lancet Date: 2011-07-16 Impact factor: 79.321
Authors: K E Bharucha; J Sastry; A Shrotri; S Sutar; A Joshi; A V Bhore; M A Phadke; R C Bollinger; A V Shankar Journal: Int J STD AIDS Date: 2005-08 Impact factor: 1.359
Authors: Marc Bulterys; Denise J Jamieson; Mary Jo O'Sullivan; Mardge H Cohen; Robert Maupin; Steven Nesheim; Mayris P Webber; Russell Van Dyke; Jeffrey Wiener; Bernard M Branson Journal: JAMA Date: 2004-07-14 Impact factor: 56.272
Authors: Michael E Herce; Tiwonge Mtande; Frank Chimbwandira; Innocent Mofolo; Christine K Chingondole; Nora E Rosenberg; Kathy E Lancaster; Esmie Kamanga; Jacqueline Chinkonde; Wiza Kumwenda; Gerald Tegha; Mina C Hosseinipour; Irving F Hoffman; Francis E Martinson; Eva Stein; Charles M van der Horst Journal: BMC Infect Dis Date: 2015-08-12 Impact factor: 3.090